Visualizing dopamine transporter integrity with iodine-123-FP-CIT SPECT in combination with high resolution MRI in the brain of the common marmoset monkey

Journal of Neuroscience Methods

Volumn 210, Issue 2, 2012, Pages 195-201

  Garea Rodríguez, Enrique ^a   Schlumbohm, Christina ^b   Czéh, Boldizsár ^a,c   König, Jessica ^a,d   Helms, Gunther ^d   Heckmann, Cornelia ^a   Meller, Birgit ^d,e   Meller, Johannes ^d   Fuchs, Eberhard ^a,d  

^a GERMAN PRIMATE CENTER   (Germany)

^b Encepharm   (Germany)

^c MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^d UNIVERSITY OF GÖTTINGEN   (Germany)

^e MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

6 OHDA; Dopamine transporter; Marmoset monkey; MRI; Parkinson's disease; SPECT

Indexed keywords

DOPAMINE TRANSPORTER; IOFLUPANE I 123; OXIDOPAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORPUS STRIATUM; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG UPTAKE; HAPLORHINI; MALE; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN BINDING; RADIOACTIVITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADRENERGIC AGENTS; ANIMALS; BRAIN; BRAIN MAPPING; CALLITHRIX; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; FUNCTIONAL LATERALITY; MAGNETIC RESONANCE IMAGING; MALE; OXIDOPAMINE; PROTEIN BINDING; PSYCHOMOTOR PERFORMANCE; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES;

EID: 84865321532     PISSN: 01650270     EISSN: 1872678X     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2012.07.009     Document Type: Article

References (35)

1. Alvarez-Fischer D., Blessmann G., Trosowski C., Behe M., Schurrat T., Hartmann A., et al. Quantitative [(123)I]FP-CIT pinhole SPECT imaging predicts striatal dopamine levels, but not number of nigral neurons in different mouse models of Parkinson's disease. Neuroimage 2007, 38:5-12.
2. Andringa G., Drukarch B., Bol J.G., de Bruin K., Sorman K., Habraken J.B., et al. Pinhole SPECT imaging of dopamine transporters correlates with dopamine transporter immunohistochemical analysis in the MPTP mouse model of Parkinson's disease. Neuroimage 2005, 26:1150-1158.
3. Annett L.E., Martel F.L., Rogers D.C., Ridley R.M., Baker H.F., Dunnett S.B. Behavioural assessment of the effects of embryonic nigral grafts in marmosets with unilateral 6-OHDA lesions of the nigrostriatal pathway. Exp Neurol 1994, 125:228-246.
4. Annett L.E., Rogers D.C., Hernandez T.D., Dunnett S.B. Behavioural analysis of unilateral monoamine depletion in the marmoset. Brain 1992, 115(Pt. 3):825-856.
5. Arnt J., Christensen A.V., Hyttel J. Pharmacology in vivo of the phenylindan derivative, Lu 19-005, a new potent inhibitor of dopamine, noradrenalin and 5-hydroxytryptamine uptake in rat brain. Naunyn Schmiedebergs Arch Pharmacol 1985, 329:101-107.
6. Baldwin R.M., Zea-Ponce Y., Al-Tikriti M.S., Zoghbi S.S., Seibyl J.P., Charney D.S., et al. Regional brain uptake and pharmacokinetics of [123I]N-omega-fluoroalkyl-2 beta-carboxy-3 beta-(4-iodophenyl)nortropane esters in baboons. Nucl Med Biol 1995, 22:211-219.
7. Beekman F., van der Have F. The pinhole: gateway to ultra-high-resolution three-dimensional radionuclide imaging. Eur J Nucl Med Mol Imaging 2007, 34:151-161.
8. Bergström K., Halldin C., Lundkvist, Swahn C.G., Akerman K.K., Kuikka J.T., et al. Characterization of C-11 or I-123 labelled β-CIT-FP and β-CIT-FE metabolism measured in monkey and human plasma. Identification of two labelled metabolites with HPLC. Hum Psychopharmacol 1996, 11:483-490.
9. Bock N.A., Kocharyan A., Liu J.V., Silva A.C. Visualizing the entire cortical myelination pattern in marmosets with magnetic resonance imaging. J Neurosci Methods 2009, 185:15-22.
10. Booij J., Andringa G., Rijks L.J., Vermeulen R.J., De Bruin K., Boer G.J., et al. [123I]FP-CIT binds to the dopamine transporter as assessed by biodistribution studies in rats and SPECT studies in MPTP-lesioned monkeys. Synapse 1997, 27:183-190.
11. Booij J., Busemann Sokole E., Stabin M.G., Janssen A.G., de Bruin K., van Royen E.A. Human biodistribution and dosimetry of [123I]FP-CIT: a potent radioligand for imaging of dopamine transporters. Eur J Nucl Med 1998, 25:24-30.
12. Booij J., de Bruin K., Habraken J.B., Voorn P. Imaging of dopamine transporters in rats using high-resolution pinhole single-photon emission tomography. Eur J Nucl Med Mol Imaging 2002, 29:1221-1224.
13. Dauer W., Przedborski S. Parkinson's disease: mechanisms and models. Neuron 2003, 39:889-909.
14. de la Fuente-Fernández R. Role of DaTSCAN and clinical diagnosis in Parkinson disease. Neurology 2012, 78:696-701.
15. Eslamboli A., Baker H.F., Ridley R.M., Annett L.E. Sensorimotor deficits in a unilateral intrastriatal 6-OHDA partial lesion model of Parkinson's disease in marmoset monkeys. Exp Neurol 2003, 183:418-429.
16. Eslamboli A., Romero-Ramos M., Burger C., Bjorklund T., Muzyczka N., Mandel R.J., et al. Long-term consequences of human alpha-synuclein overexpression in the primate ventral midbrain. Brain 2007, 130:799-815.
17. Heinz A., Jones D.W., Gorey J.G., Knable M.B., Lee K.S., Saunders R.C., et al. Analysis of the metabolites of [I-123] beta-CIT in plasma of human and nonhuman primates. Synapse 1997, 25:306-308.
18. Hyttel J. Citalopram - pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog Neuropsychopharmacol Biol Psychiatry 1982, 6:277-295.
19. Jack C.R., Bernstein M.A., Fox N.C., Thompson P., Alexander G., Harvey D., et al. The alzheimer's disease neuroimaging initiative (ADNI): MRI methods. J Magn Reson Imaging 2008, 27:685-691.
20. Kirik D., Annett L.E., Burger C., Muzyczka N., Mandel R.J., Bjorklund A. Nigrostriatal alpha-synucleinopathy induced by viral vector-mediated overexpression of human alpha-synuclein: a new primate model of Parkinson's disease. Proc Natl Acad Sci U S A 2003, 100:2884-2889.
21. Kuikka J.T., Bergstrom K.A., Ahonen A., Hiltunen J., Haukka J., Lansimies E., et al. Comparison of iodine-123 labelled 2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and 2 beta-carbomethoxy-3 beta-(4-iodophenyl)-N-(3-fluoropropyl)nortropane for imaging of the dopamine transporter in the living human brain. Eur J Nucl Med 1995, 22:356-360.
22. Laruelle M., Baldwin R.M., Malison R.T., Zea-Ponce Y., Zoghbi S.S., Al-Tikriti M.S., et al. SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT: pharmacological characterization of brain uptake in nonhuman primates. Synapse 1993, 13:295-309.
23. Lauwers E., Beque D., Van Laere K., Nuyts J., Bormans G., Mortelmans L., et al. Non-invasive imaging of neuropathology in a rat model of alpha-synuclein overexpression. Neurobiol Aging 2007, 28:248-257.
24. Lundkvist C., Halldin C., Swahn C.G., Hall H., Karlsson P., Nakashima Y., et al. [O-methyl-11C]beta-CIT-FP, a potential radioligand for quantitation of the dopamine transporter: preparation, autoradiography, metabolite studies, and positron emission tomography examinations. Nucl Med Biol 1995, 22:905-913.
25. Ma K.H., Huang W.S., Chen C.H., Lin S.Z., Wey S.P., Ting G., et al. Dual SPECT of dopamine system using [99mTc]TRODAT-1 and [123I]IBZM in normal and 6-OHDA-lesioned formosan rock monkeys. Nucl Med Biol 2002, 29:561-567.
26. Mansfield K. Marmoset models commonly used in biomedical research. Comp Med 2003, 53:383-392.
27. Neumeyer J.L., Wang S., Gao Y., Milius R.A., Kula N.S., Campbell A., et al. N-omega-fluoroalkyl analogs of (1R)-2 beta-carbomethoxy-3 beta-(4-iodophenyl)-tropane (beta-CIT): radiotracers for positron emission tomography and single photon emission computed tomography imaging of dopamine transporters. J Med Chem 1994, 37:1558-1561.
28. Orsi A., Rees D., Andreini I., Venturella S., Cinelli S., Oberto G. Overview of the marmoset as a model in nonclinical development of pharmaceutical products. Regul Toxicol Pharmacol 2011, 59:19-27.
29. 123I-PE2I SPECT. Neuroimage 2003, 19:810-816.
30. Saji H., Iida Y., Kawashima H., Ogawa M., Kitamura Y., Mukai T., et al. In vivo imaging of brain dopaminergic neurotransmission system in small animals with high-resolution single photon emission computed tomography. Anal Sci 2003, 19:67-71.
31. Schramm N.U., Ebel G., Engeland U., Schurrat T., Béhé M., Behr T.M. High-resolution SPECT using multipinhole collimation. IEEE Trans Nucl Sci 2003, 50:315-320.
32. Seibyl J.P., Marek K., Sheff K., Zoghbi S., Baldwin R.M., Charney D.S., et al. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients. J Nucl Med 1998, 39:1500-1508.
33. Stephan H., Baron G., Schwerdtfeger W.K. The brain of the common marmoset (Callathrix jacchus). A stereotaxic atlas 1980, Springer-Verlag, Berlin.
34. Swan R.C., Madisso H., Pitts R.F. Measurement of extracellular fluid volume in nephrectomized dogs. J Clin Invest 1954, 33:1447-1456.
35. Yuasa S., Nakamura K., Kohsaka S. Stereotaxic atlas of the marmoset brain: with immunohistochemical architecture and MR images 2010, Tokyo, National Institute of Neuroscience (JP).